Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Can-Fite BioPharma Ltd. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +3 vs. Q3 2021
- Shares held
- 486.0K
- −976.4K (−66.8%) vs. Q3 2021
- Total value
- $626.5K
- −$1.80M (−74.2%) vs. Q3 2021
- New holders
- 5
- 1 more added
- Sold out
- 2
- 1 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CANF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $149.1K |
| Q1 2026 | 14 | $428.6K |
| Q4 2025 | 16 | $78.3K |
| Q3 2025 | 16 | $952.6K |
| Q2 2025 | 16 | $950.1K |
| Q1 2025 | 14 | $193.9K |
| Q4 2024 | 13 | $185.9K |
| Q3 2024 | 12 | $1.52M |
| Q2 2024 | 11 | $1.62M |
| Q1 2024 | 8 | $1.06M |
| Q4 2023 | 9 | $536.4K |
| Q3 2023 | 9 | $179.2K |
| Q2 2023 | 7 | $167.8K |
| Q1 2023 | 9 | $843.5K |
| Q4 2022 | 11 | $262.2K |
| Q3 2022 | 12 | $380.5K |
| Q2 2022 | 12 | $464.7K |
| Q1 2022 | 13 | $472.3K |
| Q4 2021 | 15 | $626.5K |
| Q3 2021 | 12 | $2.43M |
| Q2 2021 | 12 | $1.05M |
| Q1 2021 | 15 | $1.09M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Can-Fite BioPharma Ltd.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 238,455 | $308.0K | 0.00% | +41,780+21.2% | Added |
| Cetera Advisor Networks LLC | 130,776 | $169.0K | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 30,000 | $39.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 28,601 | $36.0K | 0.00% | −86,206−75.1% | Reduced |
| Two Sigma Securities, LLC | 17,809 | $23.0K | 0.00% | +17,809 | New |
| Stifel Financial Corp | 12,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 11,900 | $15.0K | 0.00% | +11,900 | New |
| National Bank of Canada | 6,000 | $8.00K | 0.00% | +6,000 | New |
| Citigroup Inc | 5,535 | $7.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 1,100 | $1.42K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,114 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 499 | $1.00K | 0.00% | +499 | New |
| Federation des caisses Desjardins du Quebec | 533 | $688 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 203 | $354 | 0.00% | +203 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −875,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −93,405−100.0% | Sold out |